These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2866977)

  • 21. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term effect of a beta-adrenergic agonist on Na+/K(+)-ATPase activity in rat lung explants].
    Suzuki S; Kurosawa H; Koike K; Ono S; Tanita T; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34(12):1311-6. PubMed ID: 9022312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The central noradrenergic transmission and the locus coeruleus: a review of the data, and their implications for neurotransmission and neuromodulation.
    van Dongen PA
    Prog Neurobiol; 1981; 16(2):117-43. PubMed ID: 6116259
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ratio of brain synaptosome Na, K-ATPase to dopamine receptors].
    Glebov RN; Zholob GI; Komissarov IV
    Biull Eksp Biol Med; 1987 Oct; 104(10):430-2. PubMed ID: 2890383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Agonists of the beta adrenergic receptors of the bronchial tree].
    Pacheco CR
    Gac Med Mex; 1981 Dec; 117(12):474-5. PubMed ID: 6123461
    [No Abstract]   [Full Text] [Related]  

  • 28. Selectivity of beta-adrenergic compounds. III - Classification of beta-receptors.
    Grana E; Lucchelli A; Zonta F
    Farmaco Sci; 1974 Oct; 29(10):786-92. PubMed ID: 4154868
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS. Systemic Inflammatory Response Syndrome.
    Tighe D; Moss R; Bennett D
    New Horiz; 1996 Nov; 4(4):426-42. PubMed ID: 8968976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of dl-demethyl coclaurine on beta-adrenergic receptors and adenylate cyclase in turkey erythrocyte membrane].
    Feng YP; Jia HJ; Zhang LY; Zeng GY
    Yao Xue Xue Bao; 1982 Sep; 17(9):641-6. PubMed ID: 6130668
    [No Abstract]   [Full Text] [Related]  

  • 31. Defective renal dopamine D1 receptor function contributes to hyperinsulinemia-mediated hypertension.
    Ahmad Banday A; Lokhandwala MF
    Clin Exp Hypertens; 2006 Nov; 28(8):695-705. PubMed ID: 17132536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
    Jacinto SM; Jandhyala BS
    Ann N Y Acad Sci; 1994 Jun; 723():349-52. PubMed ID: 7913299
    [No Abstract]   [Full Text] [Related]  

  • 33. Noradrenergic agonists and antagonists: effects on avoidance behaviour in rats.
    Obersztyn M; Kostowski W
    Acta Physiol Pol; 1983; 34(4):401-7. PubMed ID: 6145294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of renal adrenergic receptor on renin secretion after the stimulation with parasympathomimetic drug].
    Shigetomi S; Hashimoto S; Fukuchi S; Hata S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):305-12. PubMed ID: 6288986
    [No Abstract]   [Full Text] [Related]  

  • 36. Sodium pump in skeletal muscle: central nervous system-induced suppression by alpha-adrenoreceptors.
    Akaike N
    Science; 1981 Sep; 213(4513):1252-4. PubMed ID: 6267696
    [No Abstract]   [Full Text] [Related]  

  • 37. Adaptive changes in catecholamine receptors in the central nervous system.
    Reisine T
    Neuroscience; 1981; 6(8):1471-502. PubMed ID: 6115335
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopamine and natriuresis. Molecular aspects and physiopathological significance].
    Bertorello AM
    Medicina (B Aires); 1992; 52(1):72-8. PubMed ID: 1338799
    [No Abstract]   [Full Text] [Related]  

  • 39. A preliminary report: neuroendocrine effects of dopamine and norepinephrine receptor stimulators.
    Jimerson DC; Post RM; Skyler J; Bunney WE
    Psychopharmacol Bull; 1976 Oct; 12(4):24-6. PubMed ID: 972979
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions of adrenergic compounds with brain membrane constituents.
    Harris WE; Stahl WL
    Biochem Pharmacol; 1978; 27(16):2015-9. PubMed ID: 31163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.